JP
PMC

John Paulson’s PharMerica Corporation PMC Stock Holding History

John Paulson’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-496,000
Closed -$17.4M – 105
2015
Q4 		$17.4M Buy
496,000
+46,000
+10% +$1.44M 0.1% 45
2015
Q3 		$12.8M Sell
450,000
-50,000
-10% -$1.68M 0.07% 55
2015
Q2 		$16.6M Buy
+500,000
New +$15.3M 0.08% 51

Other funds holding PMC

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCP
Lombardia Capital Partners Pasadena, California $110M AUM 13.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

John Paulson's PMC Position: Q1 2016 in Review

John Paulson sold out of PharMerica Corporation (PMC) in Q1 2016, closing a stake of 496,000 shares — an estimated $17.4M sold.

John Paulson first reported a position in PMC in Q2 2015 and held it in 3 quarters. The position peaked at $17.4M in Q4 2015. 169 funds tracked by Wall St. Rank hold PMC as of Q1 2016.

  • John Paulson reported no remaining PharMerica Corporation position as of Q1 2016 after selling out during the quarter.
  • John Paulson sold 496,000 PharMerica Corporation shares in Q1 2016, an estimated $17.4M.
  • John Paulson first reported a position in PharMerica Corporation in Q2 2015 and held it in 3 quarters.
  • John Paulson's PharMerica Corporation position peaked at $17.4M in Q4 2015.
  • 169 funds tracked by Wall St. Rank held PharMerica Corporation as of Q1 2016.

Based on Paulson & Co's 13F filing for Q1 2016, filed 16 May 2016.